Loading the section…
The price of PROCEPT BioRobotics Corporation (PRCT) on October 9, 2026 is 18.40 USD, +2.79% on the day. Over 52 weeks the stock traded between 16.66 USD and 38.11 USD; the price now sits 8% of the way up that range. Over the past year the price changed by -47.05%. Market capitalization is 1.05 billion USD, rank 32 among 98 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −44.24 %
PROCEPT BioRobotics Corporation trades on Nasdaq under the ticker PRCT. The company belongs to the Health care sector. The trading history on this page starts on 15 September 2021.
Over the past 52 weeks PRCT has traded between 16.67 $ and 38.11 $. As of 9 October 2026 the price stood 8.09 % of the way from the 52-week low to the high.
Over one year PRCT shares fell 47.05 %; over six months they fell 20.69 %. Volatility over 90 days is 61.91 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 3.3, below the sector median of 4.0. Price to book is 3.0, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 17.78 | 18.44 | 17.78 | 18.40 | 1M |
| 8 October 2026 | 17.80 | 18.03 | 17.52 | 17.90 | 1M |
| 7 October 2026 | 17.63 | 18.46 | 17.63 | 17.91 | 1M |
| 6 October 2026 | 17.82 | 18.00 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
PROCEPT BioRobotics Corporation (PRCT) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 322.0m $, net income was -102.5m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:150 BAYTECH DRIVE, SAN JOSE, CA, 95134, US
PROCEPT BioRobotics Corporation reported revenue of 322M $ and a net loss of 102M $ over the last four quarters. Net margin is −31.82 %. Revenue changed by +29.26 % year over year. Earnings per share are −1.83 $. Market capitalisation is 1.0B $.
PRCT has a return on equity of −29.47 %, above the sector median of −41.68 %. Return on assets is −21.04 %, above the sector median of −32.11 %. Operating margin is −33.86 %, below the sector median of −26.84 %.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 17.22 |
| 17.51 |
| 949,300 |
| 5 October 2026 | 17.16 | 18.09 | 17.13 | 17.82 | 971,000 |
| 2 October 2026 | 17.19 | 17.91 | 16.95 | 17.16 | 1M |
| 1 October 2026 | 18.26 | 18.46 | 16.74 | 17.02 | 2M |
| 30 September 2026 | 18.09 | 18.50 | 17.69 | 18.22 | 2M |
| 29 September 2026 | 17.37 | 18.67 | 16.80 | 18.22 | 2M |
| 28 September 2026 | 17.23 | 17.46 | 16.80 | 17.25 | 2M |
| 25 September 2026 | 17.37 | 17.69 | 17.05 | 17.20 | 2M |
| 24 September 2026 | 18.22 | 18.40 | 17.25 | 17.50 | 1M |
| 23 September 2026 | 18.34 | 18.62 | 17.95 | 18.09 | 914,700 |
| 22 September 2026 | 18.87 | 19.20 | 18.40 | 18.43 | 1M |
| 21 September 2026 | 19.31 | 19.38 | 18.41 | 18.51 | 1M |
| 18 September 2026 | 19.42 | 19.51 | 18.99 | 19.30 | 1M |
| 17 September 2026 | 19.58 | 19.58 | 19.04 | 19.47 | 850,000 |
| 16 September 2026 | 19.20 | 19.96 | 18.90 | 19.44 | 1M |
| 15 September 2026 | 20.82 | 20.91 | 19.23 | 19.30 | 2M |
| 14 September 2026 | 20.58 | 21.50 | 20.58 | 21.02 | 2M |